Related Experiment Video
Updated: May 22, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Distal protection device aggravated microvascular obstruction evaluated by cardiac MR after primary percutaneous
Chang-Hwan Yoon1, Woo-Young Chung, Jung-Won Suh
1Division of Cardiology, Department of Internal Medicine, Seoul National University Bundang Hospital, Republic of Korea.
Insights
Distal protection and thrombus aspiration (DP-TA) did not improve outcomes in ST-elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI). This strategy potentially increased microvascular obstruction, suggesting DP-TA should not be used in STEMI.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiovascular Imaging
Background:
- Distal protection and thrombus aspiration (DP-TA) aims to prevent distal embolization during primary percutaneous intervention (PCI) for ST-elevation myocardial infarction (STEMI).
- Previous randomized trials have not demonstrated improved microvascular circulation or reduced myocardial injury with DP-TA.
- This prospective randomized trial investigated the mechanism behind the limited efficacy of DP-TA in STEMI patients.
Purpose of the Study:
- To investigate the mechanism of the poor effect of distal protection and thrombus aspiration (DP-TA) in STEMI patients undergoing primary PCI.
- To evaluate the impact of DP-TA on left ventricular remodeling and myocardial injury compared to conventional PCI (c-PCI).
Main Methods:
- A prospective randomized trial involving 126 STEMI patients assigned to either DP-TA or c-PCI.
- Primary endpoint: Left ventricular end-diastolic volume (LVEDV) measured by cardiac MRI at post-PCI and 6 months.
- Secondary endpoints: Infarct ratio, area at risk (AAR) ratio, microvascular occlusion (MVO) ratio, and myocardial salvage index (MSI) assessed by cardiac MRI within 3 days post-PCI.
Main Results:
- No significant difference in LV remodeling (LVEDV) at 6 months between DP-TA and c-PCI groups.
- Infarct ratio, AAR ratio, and MSI were similar between the groups.
- A significantly larger MVO ratio was observed in the DP-TA group compared to the c-PCI group (p=0.045).
Conclusions:
- Distal protection and thrombus aspiration (DP-TA) was found to be potentially hazardous in primary PCI for STEMI.
- DP-TA was associated with an increased microvascular obstruction (MVO).
- The findings suggest that DP-TA should not be used in the management of STEMI.
Background:
Protection of distal embolization by balloon occlusion and thrombus aspiration has not improved microvascular circulation nor decreased myocardial injury during primary percutaneous intervention (PCI) for ST-elevation myocardial infarction (STEMI) in randomized trials. In a prospective randomized trial, we investigated the mechanism of the poor effect of distal protection and thrombus aspiration (DP-TA) in 126 patients with STEMI.
Methods:
Patients with first-diagnosed STEMI were randomly assigned to DP-TA pretreatment or conventional PCI (c-PCI). Primary endpoint was reduced left ventricular end-diastolic volume (LVEDV) measured by MRI at post-PCI and 6 months after PCI. Secondary end points were infarct ratio (infarct size to entire LV size) by delayed enhancement (DE), area at risk (AAR) ratio (AAR to entire LV size) by T2 high signal, microvascular occlusion index (MVO) ratio (MVO to entire LV size) by DE, and myocardial salvage index (MSI: (AAR--infarct size)*100/AAR) using cardiac magnetic resonance imaging (MRI) within 3 days after PCI.
Results:
Baseline characteristics of the patients including cardiovascular risk factors and lesion characteristics were similar between the two groups. DT-PA failed to improve LV remodeling at 6 months (LVEDV 140 ± 39 vs 133 ± 37 in c-PCI group, p=0.418). Infarct ratio, AAR ratio and MSI were not statistically different between DP-TA group and c-PCI group. However, MVO ratio was significantly larger in DP-TA group than in c-PCI group (2.4 ± 2.7 vs 1.1 ± 1.9, p=0.045).
Conclusion:
DP-TA was potentially hazardous in primary PCI for STEMI by increasing MVO. DP-TA should not be used in STEMI.
More Related Videos
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management

